New Pub! "Medical Cannabis Dosing Trajectories of Patients" in @clinthe!
We analyzed THC & CBD dosing in 16,000+ NY patients, finding 6 trajectories. Real-world insights to guide providers, patients, & policymakers.
https://t.co/xOJ29B0TfW
#MedicalCannabis#THC#CBD@NORCNews
Just presented Cannabis Liberalization Evidence and Gap Map presented at #LxAddictions2022. Online and fully interactive tool: https://t.co/FHOJLaMVes. Check it out! @NIDAnews@gsucjc
This week we held the 15th Annual International Society for the Study of Drug Policy Conference in Lisbon. It was such a treat to see everyone and to discuss and debate the latest #DrugPolicy issues & scholarship.
ππ€ππ€π
#ISSDP2022
So happy to be back in Lisbon! Excited to present and also learn about new drug policy research happening around the world at #ISSDP and #LxAddictions22!
Mentors, never underestimate the power of telling someone you mentor that they are on track to achieving their goals.
It may be obvious to you, but far less clear to the person who you mentor, and your words can have impact in building confidence and sense of belonging.
Our study using point-of-sale data from tens of thousands medical cannabis patients finds considerable variability in patient product choice, even for patients with the same condition. Now live @JAMANetworkOpen! https://t.co/NEfSO6Xd3P @PaculaRosalie@JAMANetwork @SchaefferCenter
Yesterday was my last day of working at Google. Perhaps this comes as surprise to you twitter folks, as I haven't widely announced that I left academia to try something new. Here's what I learned in 9 months as a Data Analyst who (temporarily) left Astronomy for Big Tech. 1/n